Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccination with recombinant lymphoma idiotype in indolent lymphoma in advanced stages
DRKS00000227Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of recombinant lymphoma idiotype vaccine in low-grade B-cell lymphoma, follicular lymphoma (FL), diffuse well-differentiated lymphocytic lymphoma (DLWD) and 1 more, sponsored by Universitätsklinikum Freiburg. Started Oct 2009; status: completed.
02
Drugs
recombinant lymphoma idiotype vaccine
03
Conditions
low-grade B-cell lymphomafollicular lymphoma (FL)diffuse well-differentiated lymphocytic lymphoma (DLWD)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on DRKS00000227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000227.